Alan Gerber
- Aging top 2%
-
- Circadian rhythm and melatonin 5
- Physiology top 10%
- Adipose Tissue and Metabolism 3
-
- Photoreceptor and optogenetics research 2
-
- RNA Research and Splicing 5
- Chemical Synthesis and Analysis 4
- Cancer-related gene regulation 4
- RNA modifications and cancer 3
- RNA and protein synthesis mechanisms 3
- Co-authors
- Ueli SchiblerFlore SinturelRobert G. RoederCamille SainiPauline GosselinYann EmmeneggerThomas CurieGianpaolo Rando
- Journals
- Cell (2 papers)Angewandte Chemie International Edition (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- NetherlandsUnited StatesSwitzerland
In The Last Decade
Alan Gerber
19 papers receiving 854 citations
Peers
Comparison fields: 5 of 89
- Aging 103
- Endocrine and Autonomic Systems 387
- Physiology 295
- Health, Toxicology and Mutagenesis 116
- Cellular and Molecular Neuroscience 85
Countries citing papers authored by Alan Gerber
This map shows the geographic impact of Alan Gerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Gerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Gerber more than expected).
Fields of papers citing papers by Alan Gerber
This network shows the impact of papers produced by Alan Gerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Gerber. The network helps show where Alan Gerber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan Gerber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 7 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 48 | |
| 10 | 2021 | 9 | |
| 11 | 2020 | 26 | |
| 12 | 2020 | 10 | |
| 13 | 2020 | 45 | |
| 14 | 2017 | 144 | |
| 15 | 2015 | 237 | |
| 16 | 2015 | 30 | |
| 17 | 2013 | 117 | |
| 18 | 2009 | 133 | |
| 19 | 2007 | 35 |
About Alan Gerber
Alan Gerber is a scholar working on Aging, Endocrine and Autonomic Systems and Developmental Neuroscience, having authored 19 papers that have together received 860 indexed citations. Recurring topics across this work include Circadian rhythm and melatonin (5 papers), RNA Research and Splicing (5 papers), Chemical Synthesis and Analysis (4 papers), Cancer-related gene regulation (4 papers), Adipose Tissue and Metabolism (3 papers), RNA modifications and cancer (3 papers), RNA and protein synthesis mechanisms (3 papers) and Photoreceptor and optogenetics research (2 papers). The work is most often cited by research in Aging (103 citations), Endocrine and Autonomic Systems (387 citations) and Physiology (295 citations). Alan Gerber has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Ueli Schibler, Flore Sinturel, Robert G. Roeder, Camille Saini, Pauline Gosselin, Yann Emmenegger, Thomas Curie, Gianpaolo Rando, Ivana Gotić and Pascal Gos. Their work appears in journals such as Cell, Angewandte Chemie International Edition, Proceedings of the National Academy of Sciences, Molecular Cell and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.